Pharmacology of imatinib (STI571).

European journal of cancer (Oxford, England : 1990)

Volumn 38 Suppl 5, Issue , 2002, Pages

  Buchdunger, Elisabeth ^a   O'Reilly, Terence ^a   Wood, Jeanette ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; IMATINIB; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; STEM CELL FACTOR RECEPTOR;

CHRONIC MYELOID LEUKEMIA; CONNECTIVE TISSUE TUMOR; DRUG ANTAGONISM; GASTROINTESTINAL TUMOR; HUMAN; REVIEW; STROMA CELL;

ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; GASTROINTESTINAL NEOPLASMS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; NEOPLASMS, CONNECTIVE TISSUE; PIPERAZINES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; STROMAL CELLS;

MLCS; MLOWN;

EID: 0036769158     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(02)80600-1     Document Type: Review

References (58)